Hypothermic oxygenated machine perfusion (HOPE) has emerged as a transformative approach to improving liver transplantation (LTx) outcomes. University of Wisconsin (UW) solution is the standard for machine perfusion; however, histidine-tryptophan-ketoglutarate (HTK), widely used as a preservation solution, offers a potential alternative in order to avoid a switch between the type of solution during organ processing.
In this webinar, we will discuss the feasibility and efficacy of a single solution strategy using HTK as a viable alternative to UW as a perfusion solution during HOPE for liver grafts.
We look forward to your participation!
Your Köhler Campus team
About the Event
LIVE WEBINAR
Hypothermic oxygenated machine perfusion of liver grafts using HTK
Moderation: Dr. Stefan Fritz (Köhler Campus)
The content of this event is designed to be product and service neutral. We confirm that the scientific management and the speakers disclose potential conflicts of interest to the participants. There is no sponsorship of the event, the total expenses of the event are about 750 €.
Kindly supported by
Dr. Franz Köhler Chemie GmbH
Werner-von-Siemens-Str. 14-28
64625 Bensheim
www.koehler-chemie.com
© 2025 Dr. Franz Köhler Chemie GmbH. All rights reserved
The Speaker
a.o.Univ.-Prof. Dr. Thomas Soliman
Deputy Head of the Transplantation Department, University Clinic of General Surgery, Vienna
Registration
This event is targeted at physicians, pharmacists and healthcare professionals and is free of charge.
Register to receive the link to the live webinar using the form below.
Recording from December 9, 2025